Sienna Hwang

Wharton Graduate ‘07, CPA (MA)

[Sienna Hwang @siennh]

@MrZackMorris $ATXI for sure. Already did reverse split and offering. No risk. Micro float and huge potential. You can pump this over $50.

[Sienna Hwang @siennh]

$EFOI 5.08M float, 1M shares are held by institutions. Net float is 4.08M. I checked its FTDs, over 5.1M. Isn’t this bullish? Current shortable shares are only 900 with a fee of 148% per Fintel. These 5.1M FTDs will be settled in mid Jan (T+35).

[Sienna Hwang @siennh]

@Jonnyylove Even AZN performed phase 3 in the US and resubmitted for approval.

[Sienna Hwang @siennh]

@Jonnyylove It will have no sales relates to vaccine sales in the future.

[Sienna Hwang @siennh]

@Jonnyylove I don’t get why Bharat Bio’s WTO approval is a good news for OCGN. They are not related at all. OCGN is a contractor for Bharat to get US and Canada approval and sales thereafter. Since it failed to get FDA approval ( phase 3 should be conducted in the US to get FDA approval),

[Sienna Hwang @siennh]

@TRUExDEMON They ran out of reasons to further dilute. Shelf registered shares are excuted over years.

[Sienna Hwang @siennh]

@TRUExDEMON The company can not dilute shares whenever they want. They should have a solid reason and the financial effect should be reported from dilution. They already accumulated $20M cash from 13.3M shares offering in early Oct. Yesterday they did debt to equity swap.

[Sienna Hwang @siennh]

@MrZackMorris Please pump this one more time tomorrow.

[Sienna Hwang @siennh]

@MrZackMorris $BHAT. Strong fundamental and over $11M cash on hold. It announced very strong quaterly result with $0.003 eps and over 200% revenue increase yoy. Current price is $0.59. 3000% runner up potentially.

[Sienna Hwang @siennh]

@MrZackMorris Zack! $BBIG is ready to rocket.

[Sienna Hwang @siennh]

@MrZackMorris Good morning, Zack! $Fami is a great potential with strong financials (postive $0.05 eps in fiscal year 2020) and $87M cash on hand. Take a look. It could be more than 10X potential. #fintwit #High5StockGro https://t.co/4vo1lvtpVg

[Sienna Hwang @siennh]

@MrZackMorris Zack, people are resenting you for $Dats dropping down because you mentioned other ticker for swing play. Please tell them you still hold $Dats.

[Sienna Hwang @siennh]

@MrZackMorris Now it has $26M cash on hand with no debt. Strong buyout candidate. Next week will be an epic. Zack, your target price of $30-50 will be still good to go!

[Sienna Hwang @siennh]

@MrZackMorris Zack! Pump $PROG. Next AMC. You can make it to $70 from $2. Show your magic!

[Sienna Hwang @siennh]

@MrZackMorris Hi Zack! Check out $PROG. Gamma squeeze may trigger if it hits $2.50. SI is also over 56%.

[Sienna Hwang @siennh]

@MrZackMorris If NTRB is pumped, you can make a history triggering GME like squeeze. No institutional ownership.

[Sienna Hwang @siennh]

@MrZackMorris Zack! NTRB completed public offering and raised $6.6M cash in early Oct. Its sales are growing 150% yoy and started manufacturing Covid 19 antibody patch with its patented technology. Total outstanding shares after offering is less than 8M and current float is only 3M.